Document is current

Any future updates will be listed below

Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

Crossref DOI link: https://doi.org/10.1038/s41598-021-01417-w

Published Online: 2021-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark